Tema Heart & Health ETF HRTS

Medalist Rating as of | See Tema ETFs Investment Hub

Morningstar’s Analysis HRTS

Will HRTS outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Tema Heart & Health ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HRTS

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 46.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

11.99 7M
Healthcare

Thermo Fisher Scientific Inc

5.42 3M
Healthcare

Roche Holding AG ADR

4.46 2M
Healthcare

Merck & Co Inc

4.38 2M
Healthcare

UnitedHealth Group Inc

3.71 2M
Healthcare

Revolution Medicines Inc Ordinary Shares

3.54 2M
Healthcare

Kodiak Sciences Inc

3.50 2M
Healthcare

BridgeBio Pharma Inc

3.35 2M
Healthcare

Johnson & Johnson

3.32 2M
Healthcare

Danaher Corp

3.24 2M
Healthcare

Sponsor Center